These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 168152)

  • 41. Immune adherence hemagglutination: further observations on demonstration of antibody to varicella-zoster virus.
    Kalter ZG; Steinberg S; Gershon AA
    J Infect Dis; 1977 Jun; 135(6):1010-3. PubMed ID: 193997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences in clinical and convalescent-phase antibodies of Rhesus monkeys infected with monkey pox, tanapox, and Yaba poxviruses.
    Hall RD; Olsen RG; Pakes SP; Yohn DS
    Infect Immun; 1973 Apr; 7(4):539-46. PubMed ID: 4357602
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Serological reactivity of some monoclonal antibodies to varicella-zoster virus.
    Forghani B; Schmidt NJ; Myoraku CK; Gallo D
    Arch Virol; 1982; 73(3-4):311-7. PubMed ID: 6184037
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Complement-enhanced neutralizing antibody response to varicella-zoster virus.
    Grose C; Edmond BJ; Brunell PA
    J Infect Dis; 1979 Apr; 139(4):432-7. PubMed ID: 220336
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evidence for chronic viral infections in human arteries.
    Smith KO; Gehle WD; Sanford BA
    Proc Soc Exp Biol Med; 1974 Nov; 147(2):357-60. PubMed ID: 4373754
    [No Abstract]   [Full Text] [Related]  

  • 47. Interferon prophylaxis against simian varicella in Erythrocebus patas monkeys.
    Arvin AM; Martin DP; Gard EA; Merigan TC
    J Infect Dis; 1983 Jan; 147(1):149-54. PubMed ID: 6296238
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell-mediated immunity to varicella-zoster virus measured by virus inactivation: mechanism and blocking of the reaction by specific antibody.
    Gershon AA; Steinberg SP
    Infect Immun; 1979 Jul; 25(1):164-9. PubMed ID: 225269
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of neutralizing antibody and IgG antibody to varicella-zoster virus and of IgG antibody to membrane antigens by the immunoperoxidase technique.
    Gerna G; Achilli G; Chambers RW
    J Infect Dis; 1977 Jun; 135(6):975-9. PubMed ID: 194001
    [No Abstract]   [Full Text] [Related]  

  • 51. The vacuolating virus of monkeys. I. Isolation, growth characteristics, and inclusion body formation.
    HSIUNG GD; GAYLORD WH
    J Exp Med; 1961 Dec; 114(6):975-86. PubMed ID: 14449527
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Varicella-zoster plaque assay and plaque reduction neutralization test by the immunoperoxidase technique.
    Gerna G; Chambers RW
    J Clin Microbiol; 1976 Nov; 4(5):437-42. PubMed ID: 186483
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A single serum dilution method for the quantitation of neutralizing antibodies to varicella-zoster virus.
    Takayama M; Oya A
    Biken J; 1981 Sep; 24(3):109-18. PubMed ID: 6279092
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rotavirus antibody assays on monkey sera: a comparison of enzyme immunoassay with neutralization and complement-fixation tests.
    Stuker G; Schmidt NJ; Forghani B; Holmberg CA; Henrickson RV; Anderson JH
    Am J Vet Res; 1979 Nov; 40(11):1620-3. PubMed ID: 230760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB.
    Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K
    Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the anticomplement immunofluorescence test for detection of antibody to varicella-zoster virus.
    Preissner CM; Steinberg SP; Gershon AA; Smith TF
    J Clin Microbiol; 1982 Aug; 16(2):373-6. PubMed ID: 6288766
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potency determination of human varicella-zoster immunoglobulin by enzyme-linked immunosorbent assay, complement-fixation test and indirect fluorescent antibody tests.
    Winsnes R; Wiger D
    J Biol Stand; 1986 Oct; 14(4):351-61. PubMed ID: 3031076
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the purification of virus antigens on the production of specific complement-fixing antibodies.
    Engler R; Keairnes P
    Appl Microbiol; 1971 Apr; 21(4):653-6. PubMed ID: 4995851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical Characterization of Host Response to Simian Hemorrhagic Fever Virus Infection in Permissive and Refractory Hosts: A Model for Determining Mechanisms of VHF Pathogenesis.
    Cornish JP; Moore IN; Perry DL; Lara A; Minai M; Promeneur D; Hagen KR; Virtaneva K; Paneru M; Buechler CR; O'Connor DH; Bailey AL; Cooper K; Mazur S; Bernbaum JG; Pettitt J; Jahrling PB; Kuhn JH; Johnson RF
    Viruses; 2019 Jan; 11(1):. PubMed ID: 30650570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abortive intrabronchial infection of rhesus macaques with varicella-zoster virus provides partial protection against simian varicella virus challenge.
    Meyer C; Engelmann F; Arnold N; Krah DL; ter Meulen J; Haberthur K; Dewane J; Messaoudi I
    J Virol; 2015 Feb; 89(3):1781-93. PubMed ID: 25410871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.